지혈 및 조직 봉합제 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 재료별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Hemostasis And Tissue Sealing Agents Market Size, Share & Trends Analysis Report By Product, By Material, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

지혈 및 조직 봉합제 시장의 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 지혈 및 조직 봉합제 시장 규모는 2030년까지 144억 8,000만 달러에 달할 것으로 예측됩니다.

이 시장은 2025년부터 2030년까지 9.0%의 연평균 성장률을 보일 것으로 예상됩니다. 이러한 성장은 덜 침습적이고 회복 시간이 짧은 최소 침습 수술에 대한 선호도가 높아진 데 기인합니다. 또한 의료 기술의 발전과 수술이 필요한 만성 질환의 유병률 증가도 이러한 성장에 기여하고 있습니다. 또한 다양한 의료 전문 분야의 요구를 충족하고 다양한 의료 환경에서 효과적이고 효율적인 수술 솔루션을 제공하기 위해 개발되고 있는 지혈 및 조직 봉합제의 지속적인 혁신으로 인해 시장도 혜택을 받고 있습니다.

최소 침습 기술의 급속한 성장과 환자의 빠른 회복에 대한 수요는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다. 미국 질병통제예방센터(CDC)에 따르면 현재 미국 인구의 약 1억 5천만 명이 적어도 한 가지 이상의 만성 질환을 앓고 있으며, 이로 인해 수술을 받고 때로는 사망에까지 이르는 경우도 있습니다. 이러한 수술 건수의 증가는 결국 시장 성장을 촉진할 것으로 예상됩니다.

미국 질병통제예방센터(CDC)는 전체 미국 인구의 48% 이상이 만성 질환을 앓고 있을 것으로 추정하고 있으며, 이는 이러한 성장의 주요 동인 중 하나입니다. 지혈 및 조직 봉합제 시장도 수술 건수 증가, 노인 인구 증가, 기술 발전으로 인해 제품 수요가 증가할 것으로 예상됩니다. 여러 시장 참여자들은 시장 지위를 유지하기 위해 제품 출시, 인수합병 및 제품 승인에 집중하고 있습니다. 예를 들어, 2023년 11월, Johnson & Johnson의 의료 기술 사업부인 Ethicon은 지혈용 봉합 패치인 Ethizia를 출시하여 유럽 승인을 획득함으로써 유럽에서 의료 서비스를 제공하는 데 중요한 역할을 했습니다.

지혈 및 조직 봉합제 시장 보고서 하이라이트

• 2024년 국소 지혈제 부문은 비용 효율성, 지혈제의 빠르고 쉬운 흡수성, 조직 반응성 최소화 및 비 항원 성을 제공하기 위해 기존 치료법과 함께 사용 증가로 인해 가장 큰 시장 점유율을 차지했습니다.
• 북미 지역은 잘 구축 된 의료 인프라와 지역 내 심혈관 질환, 당뇨병 및 암의 유병률 증가로 인해 2024년 시장에서 가장 큰 점유율을 차지했습니다.
• 시장 진출기업은 다양한 지역에서 제품 도달 범위를 늘리고 가용성을 개선하기 위해 여러 가지 전략을 채택하고 있습니다.
• 주요 시장 진출기업으로는 Baxter, Johnson & Johnson, B. Braun, Smith & Nephew, Becton, Dickinson and Company 등이 있습니다.
• 재료 과학 및 생명 공학의 개발은 더 나은 성능 특성을 가진 새로운 향상된 접착제와 봉합제의 개발로 이어졌습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 지혈 및 조직 봉합제 시장의 변수, 동향, 범위

• 시장 계통의 전망
  • 상위 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 지혈 및 조직 봉합제 시장 분석 툴
  • 산업 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 지혈 및 조직 봉합제 시장 : 제품별, 추정 및 동향 분석

• 부문 대시보드
• 지혈 및 조직 봉합제 시장 : 제품 변동 분석과 시장 점유율(2023년, 2030년)
• 국소 지혈제
• 합성 지혈제

제5장 지혈 및 조직 봉합제 시장 : 재료별, 추정 및 동향 분석

• 부문 대시보드
• 지혈 및 조직 봉합제 시장 : 재료 변동 분석과 시장 점유율(2023년, 2030년)
• 젤라틴 기반 국소지혈제
• 콜라겐 기반 국소 지혈제
• ORC 기반 국소 지혈제
• 다당류 기반 국소 지혈제

제6장 지혈 및 조직 봉합제 시장 : 용도별, 추정 및 동향 분석

• 부문 대시보드
• 지혈 및 조직 봉합제 시장 : 용도 변동 분석과 시장 점유율(2023년, 2030년)
• 일반 외과
• 뇌신경외과
• 혈관 수술
• 심장혈관 수술
• 기타

제7장 지혈 및 조직 봉합제 시장 : 최종 용도별, 추정 및 동향 분석

• 부문 대시보드
• 지혈 및 조직 봉합제 시장 : 최종 용도 변동 분석과 시장 점유율(2024년, 2030년)
• 병원
• 외래수술센터(ASC)
• 기타

제8장 지혈 및 조직 봉합제 시장 : 지역별, 추정 및 동향 분석

• 지역 전망
• 지혈 및 조직 봉합제 시장 : 지역 변동 분석과 시장 점유율(2024년, 2030년)
• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제9장 경쟁 구도

• 시장 진출기업의 분류
• 주요 기업 프로파일
  • Johnson & Johnson
  • CryoLife Inc
  • Advance Medical Solution(AMS) Group Plc
  • Cohera Medical Inc
  • Integra Life Sciences Corporation
  • Pfizer
  • BD
  • Cohesion Technologies Inc
  • HyperBranch Medical Technology
  • Biomet Inc
  • Medtronic
  • B Braun Medical Inc
  • Smith &Nephew

HBR

영문 목차

영문목차

Hemostasis And Tissue Sealing Agents Market Growth & Trends:

The global hemostasis and tissue sealing agents market size is anticipated to reach USD 14.48 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.0% from 2025 to 2030. This growth can be attributed to the increasing preference towards minimally invasive surgical procedures, which are less invasive and require less recovery time. Additionally, advancements in healthcare technology and the rising prevalence of chronic diseases that require surgery are contributing to this growth. The market is also benefiting from ongoing innovation in hemostatic and tissue sealing products, which are being developed to meet the needs of a wide range of medical specialties and to provide effective and efficient surgical solutions in various healthcare settings.

The rapid growth of minimally invasive technology and the demand for faster recovery by patients are expected to promote market growth over the forecast period. According to the Centers for Disease Control and Prevention (CDC), approximately 150 million of the American population are currently suffering from at least one chronic condition, which leads to surgeries and even mortality at times. Such a rise in the number of surgeries is eventually anticipated to foster market growth.

The Centers for Disease Control and Prevention (CDC) estimates that over 48% of the entire American population is expected to suffer from chronic conditions, which is one of the key drivers of this growth. The hemostasis & tissue sealing agents market is also expected to witness an increase in product demand supported by rising surgery volumes, growth in the geriatric population, and technological advancements. Several market participants are focusing on product launches, merger & acquisitions & product approval to sustain their market position. For instance, In November 2023, Johnson & Johnson's MedTech division, Ethicon, introduced Ethizia, a hemostatic sealing patch, obtaining European approval for its launch, marking a significant addition to their medical offerings in Europe.

Hemostasis And Tissue Sealing Agents Market Report Highlights:

• In 2024, the topical hemostat segment accounted for the largest market share due to its rising use with conventional treatment to provide cost-efficiency, quick & easy absorbability of the hemostatic agent, minimal tissue reactivity, and non-antigenicity.
• The North American region held the largest share of the market in 2024 due to well-established healthcare infrastructure, and the growing prevalence of cardiovascular disorders, diabetes, and cancer within the region.
• Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas.
• Some of the major market players are Baxter, Johnson & Johnson, B. Braun, Smith & Nephew, Becton, Dickinson, and Company
• Advancements in material science and bioengineering have led to the development of new and improved adhesives and sealants with better performance characteristics.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Hemostasis & Tissue Sealing Agents Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases
    • 3.2.1.2. Rising preference towards minimally invasive surgical procedures
    • 3.2.1.3. Growing geriatric population
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Product recall & failure
• 3.3. Hemostasis & Tissue Sealing Agents Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Hemostasis & Tissue Sealing Agents Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Hemostasis & Tissue Sealing Agents Market: Product Movement Analysis & Market Share, 2023 & 2030
• 4.3. Topical Hemostats
  • 4.3.1. Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.1.1. Active
      • 4.3.1.1.1. Active market estimates and forecast 2018 to 2030 (USD Million)
    • 4.3.1.2. Mechanical
      • 4.3.1.2.1. Mechanical market estimates and forecast 2018 to 2030 (USD Million)
    • 4.3.1.3. Flowable
      • 4.3.1.3.1. Flowable market estimates and forecast 2018 to 2030 (USD Million)
    • 4.3.1.4. Adhesive & Tissue Sealant
      • 4.3.1.4.1. Adhesive & Tissue Sealant market estimates and forecast 2018 to 2030 (USD Million)
• 4.4. Synthetic Hemostats
  • 4.4.1. Synthetic Hemostasis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.1.1. Natural
      • 4.4.1.1.1. Natural market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.1.2. Adhesion Barrier
      • 4.4.1.2.1. Adhesion Barrier market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Hemostasis & Tissue Sealing Agents Market: Material Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Hemostasis & Tissue Sealing Agents Market: Material Movement Analysis & Market Share, 2023 & 2030
• 5.3. Gelatin-based Topical Hemostats
  • 5.3.1. Gelatin-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Collagen-based Topical Hemostats
  • 5.4.1. Gelatin-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. ORC-based Topical Hemostats
  • 5.5.1. ORC-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Polysaccharide-based Topical Hemostats
  • 5.6.1. Polysaccharide-based Topical Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Hemostasis & Tissue Sealing Agents Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Hemostasis & Tissue Sealing Agents Market: Application Movement Analysis & Market Share, 2023 & 2030
• 6.3. General Surgery
  • 6.3.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Neurosurgery
  • 6.4.1. Neurosurgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Vascular Surgery
  • 6.5.1. Vascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Cardiovascular Surgery
  • 6.6.1. Cardiovascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Hemostasis & Tissue Sealing Agents Market: End-use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Hemostasis & Tissue Sealing Agents Market: End-use Movement Analysis & Market Share, 2024 & 2030
• 7.3. Hospitals
  • 7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Ambulatory Surgical Centers
  • 7.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Others
  • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Hemostasis & Tissue Sealing Agents Market: Regional Estimates & Trend Analysis

• 8.1. Regional Outlook
• 8.2. Hemostasis & Tissue Sealing Agents Market: Regional Movement Analysis & Market Share, 2024 & 2030
• 8.3. North America
  • 8.3.1. North Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. Reimbursement scenario
    • 8.3.2.5. U.S. Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Reimbursement scenario
    • 8.3.3.5. Canada Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. Reimbursement scenario
    • 8.4.2.5. UK Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Reimbursement scenario
    • 8.4.3.5. Germany Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Reimbursement scenario
    • 8.4.4.5. France Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Reimbursement scenario
    • 8.4.5.5. Italy Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Reimbursement scenario
    • 8.4.6.5. Spain Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Reimbursement scenario
    • 8.4.7.5. Denmark Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Reimbursement scenario
    • 8.4.8.5. Sweden Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Reimbursement scenario
    • 8.4.9.5. Norway Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. Japan Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. China Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. India Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Reimbursement scenario
    • 8.5.5.5. South Korea Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Reimbursement scenario
    • 8.5.6.5. Australia Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Reimbursement scenario
    • 8.5.7.5. Thailand Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Brazil Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Mexico
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Reimbursement scenario
    • 8.6.3.5. Mexico Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. Argentina
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Reimbursement scenario
    • 8.6.4.5. Argentina Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Middle East & Africa
  • 8.7.1. Middle East & Africa Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. South Africa Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. Saudi Arabia Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Reimbursement scenario
    • 8.7.4.5. UAE Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Reimbursement scenario
    • 8.7.5.5. Kuwait Hemostasis & Tissue Sealing Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Key Company Profiles
  • 9.2.1. Johnson & Johnson
    • 9.2.1.1. Company overview
    • 9.2.1.2. Financial performance
    • 9.2.1.3. Product benchmarking
    • 9.2.1.4. Strategic initiatives
  • 9.2.2. CryoLife Inc
    • 9.2.2.1. Company overview
    • 9.2.2.2. Financial performance
    • 9.2.2.3. Product benchmarking
    • 9.2.2.4. Strategic initiatives
  • 9.2.3. Advance Medical Solution (AMS) Group Plc
    • 9.2.3.1. Company overview
    • 9.2.3.2. Financial performance
    • 9.2.3.3. Product benchmarking
    • 9.2.3.4. Strategic initiatives
  • 9.2.4. Cohera Medical Inc
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. Integra Life Sciences Corporation
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. Pfizer
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. BD
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Cohesion Technologies Inc
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. HyperBranch Medical Technology
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. Biomet Inc
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Product benchmarking
    • 9.2.10.4. Strategic initiatives
  • 9.2.11. Medtronic
    • 9.2.11.1. Company overview
    • 9.2.11.2. Financial performance
    • 9.2.11.3. Product benchmarking
    • 9.2.11.4. Strategic initiatives
  • 9.2.12. B Braun Medical Inc
    • 9.2.12.1. Company overview
    • 9.2.12.2. Financial performance
    • 9.2.12.3. Product benchmarking
    • 9.2.12.4. Strategic initiatives
  • 9.2.13. Smith & Nephew
    • 9.2.13.1. Company overview
    • 9.2.13.2. Financial performance
    • 9.2.13.3. Product benchmarking
    • 9.2.13.4. Strategic initiatives

관련자료